Trial Profile
Evaluation of renal blood flow on men who administer tadalafil using contrast-enhanced ultrasound
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 20 Jun 2022
Price :
$35
*
At a glance
- Drugs Tadalafil (Primary)
- Indications Benign prostatic hyperplasia; Duchenne muscular dystrophy; Erectile dysfunction; Pulmonary hypertension
- Focus Pharmacodynamics
- 13 Jun 2022 According to University Hospital Medical Information Network - Japan, Date of closure to data entry is 6 Feb 2018.
- 13 Jun 2022 Status changed from recruiting to discontinued.
- 01 Dec 2016 New trial record